JP2023554119A5 - - Google Patents
Info
- Publication number
- JP2023554119A5 JP2023554119A5 JP2023537488A JP2023537488A JP2023554119A5 JP 2023554119 A5 JP2023554119 A5 JP 2023554119A5 JP 2023537488 A JP2023537488 A JP 2023537488A JP 2023537488 A JP2023537488 A JP 2023537488A JP 2023554119 A5 JP2023554119 A5 JP 2023554119A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128601P | 2020-12-21 | 2020-12-21 | |
| US63/128,601 | 2020-12-21 | ||
| PCT/CA2021/051855 WO2022133592A1 (en) | 2020-12-21 | 2021-12-21 | Stabilized tcr constructs and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023554119A JP2023554119A (ja) | 2023-12-26 |
| JP2023554119A5 true JP2023554119A5 (https=) | 2025-01-06 |
| JPWO2022133592A5 JPWO2022133592A5 (https=) | 2025-01-06 |
Family
ID=82157307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537488A Pending JP2023554119A (ja) | 2020-12-21 | 2021-12-21 | 安定化されたｔｃｒコンストラクト及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240409604A9 (https=) |
| EP (1) | EP4263593A4 (https=) |
| JP (1) | JP2023554119A (https=) |
| KR (1) | KR20230123474A (https=) |
| CN (1) | CN116648256A (https=) |
| AU (1) | AU2021408160A1 (https=) |
| CA (1) | CA3167637A1 (https=) |
| WO (1) | WO2022133592A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202000025SA (en) | 2017-07-14 | 2020-02-27 | Immatics Biotechnologies Gmbh | Improved dual specificity polypeptide molecule |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| WO2025087436A1 (zh) * | 2023-10-27 | 2025-05-01 | 北京可瑞生物科技有限公司 | 基于t细胞受体的多特异性多肽分子及其组合物和用途 |
| WO2025140554A1 (en) * | 2023-12-29 | 2025-07-03 | Shanghai Epimab Biotherapeutics Co., Ltd. | Fusion proteins and uses thereof |
| CN118108833B (zh) * | 2024-03-12 | 2025-05-02 | 缇纱(合肥)生物技术有限公司 | 引入外源二硫键的tcr恒定区及其产品和应用 |
| WO2025214470A1 (zh) * | 2024-04-12 | 2025-10-16 | 江苏恒瑞医药股份有限公司 | 包含t细胞受体恒定区的蛋白质及其医药用途 |
| WO2025224084A1 (en) | 2024-04-22 | 2025-10-30 | Engimmune Therapeutics Ag | Proteins comprising t cell receptor constant domains |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110139873A (zh) * | 2016-10-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | Hpv特异性结合分子 |
| CN117843810A (zh) * | 2017-09-22 | 2024-04-09 | 上海药明生物技术有限公司 | 新型双特异性多肽复合物 |
| AU2018337142B2 (en) * | 2017-09-22 | 2025-07-03 | Wuxi Biologics Ireland Limited. | Novel bispecific CD3/CD19 polypeptide complexes |
| BR112020006643A2 (pt) * | 2017-10-03 | 2020-09-24 | Juno Therapeutics Inc | moléculas de ligação específica ao hpv |
| KR20210020873A (ko) * | 2018-04-05 | 2021-02-24 | 주노 쎄러퓨티크스 인코퍼레이티드 | 재조합 수용체를 발현하는 τ 세포, 관련 폴리뉴클레오티드 및 방법 |
| AU2019249209A1 (en) * | 2018-04-05 | 2020-10-15 | Juno Therapeutics, Inc. | T cell receptors and engineered cells expressing same |
-
2021
- 2021-12-21 AU AU2021408160A patent/AU2021408160A1/en not_active Abandoned
- 2021-12-21 JP JP2023537488A patent/JP2023554119A/ja active Pending
- 2021-12-21 CN CN202180086149.4A patent/CN116648256A/zh active Pending
- 2021-12-21 EP EP21908193.2A patent/EP4263593A4/en active Pending
- 2021-12-21 CA CA3167637A patent/CA3167637A1/en active Pending
- 2021-12-21 US US18/258,057 patent/US20240409604A9/en active Pending
- 2021-12-21 WO PCT/CA2021/051855 patent/WO2022133592A1/en not_active Ceased
- 2021-12-21 KR KR1020237020556A patent/KR20230123474A/ko active Pending